TOUYUN BIOTECH (01332) Revenue Breakdown - Main Composition

0.144
+0.004+2.86%

Market Closed May 8 16:08 CST

404.06MMarket Cap14.40P/E (TTM)

TOUYUN BIOTECH (01332) Revenue Breakdown Overview

By Business/Source

Currency:HKD

2025/FY

Stock NameRevenueRatio

Packaging product business62.28M86.56%

莱茵衣藻产品业务9.67M13.44%

By Product

Currency:HKD

2025/FY

Stock NameRevenueRatio

Packaging product business62.28M86.56%

莱茵衣藻产品业务9.67M13.44%

By Country/Region

Currency:HKD

2025/FY

Stock NameRevenueRatio

中国香港及中国20.95M31.29%

Europe Switzerland13.59M20.29%

Europe-others11.65M17.39%

Europe-Netherlands8.89M13.27%

Other8.42M12.57%

North and South America3.47M5.18%

View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"